Literature DB >> 6506035

A model for thrombin protection against endotoxin.

F B Taylor, A Chang, L B Hinshaw, C T Esmon, L T Archer, B K Beller.   

Abstract

Infusion of dogs with thrombin (0.5 U/kg/min) for 90 minutes significantly increased percent survival following infusion of endotoxin (0.06 mg/kg/min) for 30 minutes. Nine of fourteen dogs infused with thrombin survived seven days (permanent survivors), whereas thirteen of fourteen dogs infused with saline died within 36 hours. Those dogs which survived responded immediately to endotoxin with enhanced anticoagulant and fibrinolytic activity as measured by the Xa one-stage and fibrin degradation product assays, respectively. Those dogs receiving saline instead of thrombin did not respond with anticoagulant or fibrinolytic activity until the end of the study. We concluded that thrombin in the correct amounts protected dogs from endotoxin and that this protection was associated with an early anticoagulant and fibrinolytic response to endotoxin infusion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6506035     DOI: 10.1016/0049-3848(84)90339-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.

Authors:  Javier Corral; José Yélamos; David Hernández-Espinosa; Yolanda Monreal; Ruben Mota; Isabel Arcas; Antonia Miñano; Pascual Parrilla; Vicente Vicente
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 2.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

3.  Inflammation-associated activation of coagulation and immune regulation by the protein C pathway.

Authors:  Hartmut Weiler
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

5.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

6.  Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

7.  Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.

Authors:  Jong-Sup Bae; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2008-07       Impact factor: 5.249

Review 8.  Protein C anticoagulant system--anti-inflammatory effects.

Authors:  Charles T Esmon
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

9.  The effects of continuous venovenous hemofiltration on coagulation activation.

Authors:  Catherine S C Bouman; Anne-Cornélie J M de Pont; Joost C M Meijers; Kamran Bakhtiari; Dorina Roem; Sacha Zeerleder; Gertjan Wolbink; Johanna C Korevaar; Marcel Levi; Evert de Jonge
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 10.  Science review: role of coagulation protease cascades in sepsis.

Authors:  Matthias Riewald; Wolfram Ruf
Journal:  Crit Care       Date:  2002-10-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.